Sarepta will halt all shipments of Elevidys, its drug for Duchenne muscular dystrophy patients, by Tuesday evening.

Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that have attracted attention from regulators ...

Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that have attracted attention from regulators.

The Cambridge, Massachusetts-based company said it would “ temporarily pause all shipments” of its gene therapy Elevidys for muscular dystrophy at the close of business Tuesday.

Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy by: MATTHEW PERRONE, Associated Press Posted: Jul 22, 2025 / 11:07 AM EDT Updated: Jul 22, 2025 / 11:09 AM EDT ...